serw-MX  [xml]  

 DeCS Categories

C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.767 Postoperative Complications .
C23.550.767.879 Shock, Surgical .
C23.550.835 Shock .
C23.550.835.775 Shock, Surgical .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.157 Carrier Proteins .
D12.776.157.530 Membrane Transport Proteins .
D12.776.157.530.750 Nucleocytoplasmic Transport Proteins .
D12.776.157.530.750.625 Nuclear Pore Complex Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.585 Membrane Transport Proteins .
D12.776.543.585.750 Nucleocytoplasmic Transport Proteins .
D12.776.543.585.750.625 Nuclear Pore Complex Proteins .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.411 Cardiovascular Agents .
D27.505.954.411.793 Vasoconstrictor Agents .
D27.505.954.411.793.610 Nasal Decongestants .
D27.505.954.796 Respiratory System Agents .
D27.505.954.796.560 Nasal Decongestants .
E05 Investigative Techniques .
E05.318 Epidemiologic Methods .
E05.318.740 Statistics as Topic .
E05.318.740.998 Survival Analysis .
E05.393 Genetic Techniques .
E05.393.731 Reverse Genetics .
G07 Physiological Phenomena .
G07.345 Growth and Development .
G07.345.124 Aging .
G07.345.124.519 Longevity .
G07.540 Longevity .
H01 Natural Science Disciplines .
H01.158 Biological Science Disciplines .
H01.158.100 Anatomy .
H01.158.100.720 Osteology .
H01.158.201 Biochemistry .
H01.158.201.085 Carbohydrate Biochemistry .
H01. Glycomics .
H01.158.273 Biology .
H01.158.273.180 Computational Biology .
H01. Genomics .
H01. Glycomics .
H01.158.273.343 Genetics .
H01.158.273.343.350 Genomics .
H01.158.273.343.350.086 Glycomics .
H01.181 Chemistry .
H01.181.122 Biochemistry .
H01.181.122.508 Glycomics .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.750 Statistics as Topic .
N05.715.360.750.795 Survival Analysis .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.830 Statistics as Topic .
N06.850.520.830.998 Survival Analysis .
SP5 Epidemiology and Biostatistics .
SP5.006 Biostatistics .
SP5.006.072 Statistics as Topic .
SP5.006.072.268 Survival Analysis .
 Synonyms & Historicals
Aging .
Aging, Biological .
Biological Aging .
Senescence .
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. .
Growth and Development .
Development and Growth .
The series of changes to the shape, size, components, and functions of an individual organism that occur over time as the organism progresses from its initial form to full size and maturity. .
Glycomics .
Glycobiology .
The systematic study of the structure and function of the complete set of glycans (the glycome) produced in a single organism and identification of all the genes that encode glycoproteins. .
Shock, Surgical .
Surgical Shock .
Surgical Shocks .
A type of shock that occurs as a result of a surgical procedure. .
Reverse Genetics .
Genetics, Reverse .
The use of techniques that produce a functional MUTATION or an effect on GENE EXPRESSION of a specific gene of interest in order to identify the role or activity of the gene product of that gene. .
Osteology .
The branch of anatomy that concerns the structure and function of bones. .
Nasal Decongestants .
Vasoconstrictors, Nasal .
Agents, Nasal Vasoconstrictor .
Decongestants, Nasal .
Nasal Vasoconstrictor Agents .
Nasal Vasoconstrictors .
Decongestants .
Vasoconstrictor Agents, Nasal .
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) .
Longevity .
Length of Life .
The normal length of time of an organism's life. .
Nuclear Pore Complex Proteins .
Nucleoporin .
Nucleoporins .
Proteins that form the structure of the NUCLEAR PORE. They are involved in active, facilitated and passive transport of molecules in and out of the CELL NUCLEUS. .
Survival Analysis .
Analysis, Survival .
Analyses, Survival .
Survival Analyses .
Cox's Regression .
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. .